SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

19 May 2025 Evaluate
The sales moved down -34.55% to Rs. 244.32 millions for the March 2025 quarter as compared to Rs. 373.32 millions during the corresponding quarter last year.Profit after Tax for the quarter ended March 2025 saw a decline of -47.61% from Rs. 125.93 millions to Rs. 65.97  millions.The company reported a degrowth in operating Profit to 121.63 millions from 182.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 244.32 373.32 -34.55 1085.96 1258.95 -13.74 1085.96 1258.95 -13.74
Other Income 22.87 13.24 72.73 37.30 30.71 21.46 37.30 30.71 21.46
PBIDT 121.63 182.55 -33.37 429.42 448.77 -4.31 429.42 448.77 -4.31
Interest 9.58 1.46 556.16 20.77 5.98 247.32 20.77 5.98 247.32
PBDT 112.05 181.09 -38.12 408.65 442.79 -7.71 408.65 442.79 -7.71
Depreciation 24.24 18.57 30.53 95.67 61.10 56.58 95.67 61.10 56.58
PBT 87.81 162.52 -45.97 312.98 381.69 -18.00 312.98 381.69 -18.00
TAX 21.84 36.59 -40.31 81.99 100.52 -18.43 81.99 100.52 -18.43
Deferred Tax -0.81 -0.15 440.00 -0.45 6.74 -106.68 -0.45 6.74 -106.68
PAT 65.97 125.93 -47.61 230.99 281.17 -17.85 230.99 281.17 -17.85
Equity 128.38 125.83 2.03 128.38 125.83 2.03 128.38 125.83 2.03
PBIDTM(%) 49.78 48.90 1.81 39.54 35.65 10.93 39.54 35.65 10.93

Shree Ganesh Remed. Share Price

486.65 12.35 (2.60%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×